The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Signify Bio Partners with UT Southwestern to Advance In Situ Protein Therapeutics After $15 Million Financing.
Jun 05, 2025•about 1 year ago
Contract Type
partnership
DallasBiotechnologyTherapeutics
Description
Signify Bio has launched following an oversubscribed $15 million financing round, with a partnership formed with UT Southwestern. The company specializes in harnessing the human body to produce protein therapeutics and aims to transform the landscape of precision medicine.
Company Information
Company
Signify Bio
Location
Dallas, Texas, United States
About
Signify Bio is a biotechnology company improving the development of in situ protein therapeutics by leveraging the human body’s natural ability to produce proteins. Guided by its mission to create personalized medicines for all, it combines the precision of signal peptide engineered control with the speed and versatility of mRNA encoded design. The company’s SEND platform and iPhos lipid nanoparticles enable targeted and localized delivery of therapeutic proteins, addressing unmet needs across various diseases.
Predictive Intelligence
Strategic
ML-powered predictions for Signify Bio's next move
DallasBiotechnologyTherapeutics